ALAMEDA, California – 11 May 2017 – AllCells, a leading provider of healthy & diseased hematological/immunological tissue, primary cell-based products, clinical grade products for further manufacturing of allogeneic cell therapies, and Bioservices will be attending the 2017 Biotechnology Industry Organization (BIO) International Convention One-on-One Partnering™ program to be held in San Diego, CA, USA, 19-22 June 2017. Wayne Vaz – VP, Corporate Development, Lewis Chapman – VP, Global Commercial Operations, and James Lee, Assoc. Director Global Commercial Operations, will be available to meet at the San Diego Convention Center to discuss the company’s capabilities, strategic partnership and collaboration interests. Wayne Vaz will present an overview of AllCells’ business during the Company Presentation section of the Business Forum, including the recent launch of CliniCells™ clinical grade products for further manufacturing of allogeneic cell therapies.
According to BIO, last year’s BIO International Convention hosted 35,000+ 25 minute partnering meetings among 3,500+ companies in 3.5 days. Meetings can be pre-scheduled before you arrive in San Diego and hosted in the BIO Business Forum as well as Exhibitor Booths. BIO participants interested in learning more about AllCells or scheduling meetings to discuss partnering opportunities should login to BIO’s One-on-One Partnering™ program page. Individuals not directly participating in the Business Forum who wish to meet AllCells company representatives may contact Wayne Vaz. Lewis Chapman, or James Lee to make separate arrangements. BIO One-on-One Partnering is a trademark of the Biotechnology Industry Organization.
About AllCells, LLC
AllCells is a biotechnology company dedicated to providing researchers and biomanufacturing organizations with high quality primary cells that enable drug discovery, preclinical development, and manufacturing of cell therapies. Leveraging its expertise in hematology and immunology cell isolations together with on-site hematologic tissue clinical collection operations, AllCells maintains a large repository of donor profiles that can be qualified for various biomedical applications. Freshly collected tissue is immediately processed in contiguous manufacturing facilities to produce purified cell types having unparalleled quality and consistency. Cells are shipped worldwide, or fresh cells can be immediately utilized in fee-for-service cell-based assays (AllCellutions™) custom designed according to customer criteria. For more information, please visit www.allcells.com.